MAPK regulation of gene expression in airway smooth muscle

Respiratory Physiology and Neurobiology

Volumn 137, Issue 2-3, 2003, Pages 237-250

  Gerthoffer, William T ^a   Singer, Cherie A ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

Airway, smooth muscle; Disease, asthma; Enzyme, MAP kinases, airway smooth muscle; Gene, expression

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOVIRUS VECTOR; CHEMOKINE; CYCLOOXYGENASE 2; GROWTH FACTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NEUROTRANSMITTER; STAT PROTEIN; TRANSCRIPTION FACTOR;

ASTHMA; AUTOCRINE EFFECT; BREATHING MUSCLE; CELL CYCLE; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CELL STRUCTURE; CHEMICAL ANALYSIS; CYTOKINE PRODUCTION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC CODE; HUMAN; MEDIATOR RELEASE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN RNA BINDING; PROTEIN SYNTHESIS; RESPIRATORY TRACT INFLAMMATION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; STIMULUS; TRANSCRIPTION REGULATION; TRANSGENE;

EID: 0141680396     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9048(03)00150-2     Document Type: Article

References (99)

1. Ammit A.J., Hoffman R.K., Amrani Y., Lazaar A.L., Hay D.W., Torphy T.J., Penn R.B., Panettieri R.A. Jr. Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate. Am. J. Respir. Cell Mol. Biol. 23:2000;794-802.
2. Amrani Y., Martinet N., Bronner C. Potentiation by tumour necrosis factor-alpha of calcium signals induced by bradykinin and carbachol in human tracheal smooth muscle cells. Br. J. Pharmacol. 114:1995;4-5.
3. Amrani Y., Ammit A.J., Panettieri R.A. Jr. Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis factor-alpha-induced interleukin-6 and RANTES in human airway smooth muscle cells: role of p38 and p42/44 mitogen-activated protein kinases. Mol. Pharmacol. 60:2001;646-655.
4. Barchasz E., Naline E., Molimard M., Moreau J., Georges O., Emonds-Alt X., Advenier C. Interleukin-1beta-induced hyperresponsiveness to [Sar9,Met(O2)11]substance P in isolated human bronchi. Eur. J. Pharmacol. 379:1999;87-95.
5. Barnes P.J., Chung K.F., Page C.P. Inflammatory mediators of asthma: an update. Pharmacol. Rev. 50:1998;515-596.
6. Belvisi M.G., Saunders M.A., Haddad E., Hirst S.J., Yacoub M.H., Barnes P.J., Mitchell J.A. Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br. J. Pharmacol. 120:1997;910-916.
7. Bitar K.N. HSP27 phosphorylation and interaction with actin-myosin in smooth muscle contraction. Am. J. Physiol. Gastrointest. Liver Physiol. 282:2002;G894-G903.
8. Broide D.H., Paine M.M., Firestein G.S. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J. Clin. Invest. 90:1992;1414-1424.
9. Brook M., Sully G., Clark A.R., Saklatvala J. Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade. FEBS Lett. 483:2000;57-61.
10. Carballo E., Lai W.S., Blackshear P.J. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood. 95:2000;1891-1899.
11. Chen G., Wood E.G., Wang S.H., Warner T.D. Expression of cyclooxygenase-2 in rat vascular smooth muscle cells is unrelated to nuclear factor-kappaB activation. Life Sci. 64:1999;1231-1242.
12. Chen C.C., Sun Y.T., Chen J.J., Chiu K.T. TNF-alpha-induced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-gamma 2, protein kinase C-alpha, tyrosine kinase, NF-kappa B-inducing kinase, and I-kappa B kinase 1/2 pathway. J. Immunol. 165:2000;2719-2728.
13. Chen C.H., Zhang D.H., LaPorte J.M., Ray A. Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression. J. Immunol. 165:2000;5597-5605.
14. Chung K.F., Patel H.J., Fadlon E.J., Rousell J., Haddad E.B., Jose P.J., Mitchell J., Belvisi M. Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1beta and TNFalpha: effects of IL-10 and corticosteroids. Br. J. Pharmacol. 127:1999;1145-1150.
15. Davis R.J. Transcriptional regulation by MAP kinases. Mol. Reprod. Dev. 42:1995;459-467.
16. De S., Zelazny E.T., Souhrada J.F., Souhrada M. IL-1 beta and IL-6 induce hyperplasia and hypertrophy of cultured guinea pig airway smooth muscle cells. J. Appl. Physiol. 78:1995;1555-1563.
17. Deak M., Clifton A.D., Lucocq L.M., Alessi D.R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17:1998;4426-4441.
18. Dean J.L., Brook M., Clark A.R., Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274:1999;264-269.
19. Ebina M., Takahashi T., Chiba T., Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am. Rev. Respir. Dis. 148:1993;720-726.
20. Elias J.A., Wu Y., Zheng T., Panettieri R. Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines. Am. J. Physiol. 273:1997;L648-L655.
21. Esnault S., Malter J.S. Extracellular signal-regulated kinase mediates granulocyte-macrophage colony-stimulating factor messenger RNA stabilization in tumor necrosis factor-alpha plus fibronectin-activated peripheral blood eosinophils. Blood. 99:2002;4048-4052.
22. Finkelman F.D., Katona I.M., Urban J.F. Jr, Holmes J., Ohara J., Tung A.S., Sample J.V., Paul W.E. IL-4 is required to generate and sustain in vivo IgE responses. J. Immunol. 141:1988;2335-2341.
23. Foster P.S., Hogan S.P., Ramsay A.J., Matthaei K.I., Young I.G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:1996;195-201.
24. Gerthoffer W.T. Agonist synergism in airway smooth muscle contraction. J. Pharmacol. Exp. Ther. 278:1996;800-807.
25. Ghaffar O., Hamid Q., Renzi P.M., Allakhverdi Z., Molet S., Hogg J.C., Shore S.A., Luster A.D., Lamkhioued B. Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells. Am. J. Respir. Crit. Care Med. 159:1999;1933-1942.
26. Gille H., Strahl T., Shaw P.E. Activation of ternary complex factor Elk-1 by stress-activated protein-kinases. Curr. Biol. 5:1995;1191-1200.
27. Grunstein M.M., Hakonarson H., Leiter J., Chen M., Whelan R., Grunstein J.S., Chuang S. IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. Am. J. Physiol. Lung Cell Mol. Physiol. 282:2002;L520-L528.
28. Hakonarson H., Herrick D.J., Serrano P.G., Grunstein M.M. Autocrine role of interleukin 1beta in altered responsiveness of atopic asthmatic sensitized airway smooth muscle. J. Clin. Invest. 99:1997;117-124.
29. Hakonarson H., Maskeri N., Carter C., Chuang S., Grunstein M.M. Autocrine interaction between IL-5 and IL-1beta mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscle. J. Clin. Invest. 104:1999;657-667.
30. Hakonarson H., Maskeri N., Carter C., Grunstein M.M. Regulation of TH1- and TH2-type cytokine expression and action in atopic asthmatic sensitized airway smooth muscle. J. Clin. Invest. 103:1999;1077-1087.
31. Hallsworth M.P., Soh C.P., Twort C.H., Lee T.H., Hirst S.J. Cultured human airway smooth muscle cells stimulated by interleukin-1beta enhance eosinophil survival. Am. J. Respir. Cell Mol. Biol. 19:1998;910-919.
32. Hallsworth M.P., Moir L.M., Lai D., Hirst S.J. Inhibitors of mitogen-activated protein kinases differentially regulate eosinophil-activating cytokine release from human airway smooth muscle. Am. J. Respir. Crit. Care Med. 164:2001;688-697.
33. Hedges J.C., Dechert M.A., Yamboliev I.A., Martin J.L., Hickey E., Weber L.A., Gerthoffer W.T. A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration. J. Biol. Chem. 274:1999;24211-24219.
34. Hedges J.C., Oxhorn B.C., Carty M., Adam L.P., Yamboliev I.A., Gerthoffer W.T. Phosphorylation of caldesmon by ERK MAP kinases in smooth muscle. Am. J. Physiol. Cell Physiol. 47:2000;C718-C726.
35. Hedges J.C., Singer C.A., Gerthoffer W.T. Mitogen-activated protein kinases regulate cytokine gene expression in human airway myocytes. Am. J. Respir. Cell Mol. Biol. 23:2000;86-94.
36. Hirst S.J., Hallsworth M.P., Peng Q., Lee T.H. Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. Am. J. Respir. Crit. Care Med. 165:2002;1161-1171.
37. James A.L., Pare P.D., Hogg J.C. The mechanics of airway narrowing in asthma. Am. Rev. Respir. Dis. 139:1989;242-246.
38. Jeffery P.K. Morphology of the airway wall in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 143:1991;1152-1158. discussion 1161.
39. John M., Hirst S.J., Jose P.J., Robichaud A., Berkman N., Witt C., Twort C.H., Barnes P.J., Chung K.F. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J. Immunol. 158:1997;1841-1847.
40. John M., Au B.T., Jose P.J., Lim S., Saunders M., Barnes P.J., Mitchell J.A., Belvisi M.G., Chung K.F. Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. Am. J. Respir. Cell Mol. Biol. 18:1998;84-90.
41. Johnson S.R., Knox A.J. Synthetic functions of airway smooth muscle in asthma. Trends Pharmacol. Sci. 18:1997;288-292.
42. Karpova A.Y., Abe M.K., Li J., Liu P.T., Rhee J.M., Kuo W.L., Hershenson M.B. MEK1 is required for PDGF-induced ERK activation and DNA synthesis in tracheal myocytes. Am. J. Physiol. 272:1997;L558-L565.
43. Kelleher M.D., Abe M.K., Chao T.S., Jain M., Green J.M., Solway J., Rosner M.R., Hershenson M.B. Role of MAP kinase activation in bovine tracheal smooth muscle mitogenesis. Am. J. Physiol. 268:1995;L894-L901.
44. Knebel A., Morrice N., Cohen P. A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta. EMBO J. 20:2001;4360-4369.
45. Knight D.A., Lydell C.P., Zhou D., Weir T.D., Robert S.R., Bai T.R. Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF release. Am. J. Respir. Cell Mol. Biol. 20:1999;834-841.
46. Kondo A., Mogi M., Koshihara Y., Togari A. Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells. Biochem. Pharmacol. 61:2001;319-326.
47. Koto H., Mak J.C., Haddad E.B., Xu W.B., Salmon M., Barnes P.J., Chung K.F. Mechanisms of impaired beta-adrenoceptor-induced airway relaxation by interleukin-1beta in vivo in the rat. J. Clin. Invest. 98:1996;1780-1787.
48. Lahiri T., Laporte J.D., Moore P.E., Panettieri R.A. Jr, Shore S.A. Interleukin-6 family cytokines: signaling and effects in human airway smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 280:2001;L1225-L1232.
49. Laporte J.D., Moore P.E., Panettieri R.A., Moeller W., Heyder J., Shore S.A. Prostanoids mediate IL-1beta-induced beta-adrenergic hyporesponsiveness in human airway smooth muscle cells. Am. J. Physiol. 275:1998;L491-L501.
50. Laporte J.D., Moore P.E., Abraham J.H., Maksym G.N., Fabry B., Panettieri R.A. Jr, Shore S.A. Role of ERK MAP kinases in responses of cultured human airway smooth muscle cells to IL-1beta. Am. J. Physiol. 277:1999;L943-L951.
51. Laporte J.D., Moore P.E., Lahiri T., Schwartzman I.N., Panettieri R.A. Jr, Shore S.A. p38 MAP kinase regulates IL-1 beta responses in cultured airway smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 279:2000;L932-L941.
52. Lasa M., Mahtani K.R., Finch A., Brewer G., Saklatvala J., Clark A.R. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol. Cell. Biol. 20:2000;4265-4274.
53. Lee J.C., Young P.R. Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J. Leukocyte Biol. 59:1996;152-157.
54. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Heys J.R., Landvatter S.W. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 372:1994;739-746.
55. Levine S.J. Bronchial epithelial cell-cytokine interactions in airway inflammation. J. Invest. Med. 43:1995;241-249.
56. Lin C.H., Kuan I.H., Lee H.M., Lee W.S., Sheu J.R., Ho Y.S., Wang C.H., Kuo H.P. Induction of cyclooxygenase-2 protein by lipoteichoic acid from Staphylococcus aureus in human pulmonary epithelial cells: involvement of a nuclear factor-kappa B-dependent pathway. Br. J. Pharmacol. 134:2001;543-552.
57. Mahtani K.R., Brook M., Dean J.L., Sully G., Saklatvala J., Clark A.R. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol. Cell. Biol. 21:2001;6461-6469.
58. Maruoka S., Hashimoto S., Gon Y., Takeshita I., Horie T. PAF-induced RANTES production by human airway smooth muscle cells requires both p38 MAP kinase and Erk. Am. J. Respir. Crit. Care Med. 161:2000;922-929.
59. Mayr M., Hu Y., Hainaut H., Xu Q. Mechanical stress-induced DNA damage and rac-p38MAPK signal pathways mediate p53-dependent apoptosis in vascular smooth muscle cells. FASEB J. 16:2002;1423-1425.
60. McKay S., Sharma H.S. Autocrine regulation of asthmatic airway inflammation: role of airway smooth muscle. Respir. Res. 3:2002;11.
61. McKay S., Hirst S.J., Haas M.B., de Jongste J.C., Hoogsteden H.C., Saxena P.R., Sharma H.S. Tumor necrosis factor-alpha enhances mRNA expression and secretion of interleukin-6 in cultured human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 23:2000;103-111.
62. McLane M.P., Haczku A., van de R.M., Weiss C., Ferrante V., MacDonald D., Renauld J.C., Nicolaides N.C., Holroyd K.J., Levitt R.C. Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice. Am. J. Respir. Cell Mol. Biol. 19:1998;713-720.
63. Meja K.K., Seldon P.M., Nasuhara Y., Ito K., Barnes P.J., Lindsay M.A., Giembycz M.A. p38 MAP kinase and MKK-1 co-operate in the generation of GM-CSF from LPS-stimulated human monocytes by an NF-kappa B-independent mechanism. Br. J. Pharmacol. 131:2000;1143-1153.
64. Moore P.E., Lahiri T., Laporte J.D., Church T., Panettieri R.A. Jr, Shore S.A. Selected contribution: synergism between TNF-alpha and IL-1 beta in airway smooth muscle cells: implications for beta-adrenergic responsiveness. J. Appl. Physiol. 91:2001;1467-1474.
65. Moore P.E., Church T.L., Chism D.D., Panettieri R.A. Jr, Shore S.A. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am. J. Physiol. Lung Cell Mol. Physiol. 282:2002;L847-L853.
66. Neininger A., Kontoyiannis D., Kotlyarov A., Winzen R., Eckert R., Volk H.D., Holtmann H., Kollias G., Gaestel M. MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J. Biol. Chem. 277:2002;3065-3068.
67. Orsini M.J., Krymskaya V.P., Eszterhas A.J., Benovic J.L., Panettieri R.A. Jr, Penn R.B. MAPK superfamily activation in human airway smooth muscle: mitogenesis requires prolonged p42/p44 activation. Am. J. Physiol. 277:1999;L479-L488.
68. Page K., Hershenson M.B. Mitogen-activated signaling and cell cycle regulation in airway smooth muscle. Front Biosci. 5:2000;D258-D267.
69. Page K., Li J., Hodge J.A., Liu P.T., Vanden Hoek T.L., Becker L.B., Pestell R.G., Rosner M.R., Hershenson M.B. Characterization of a Rac1 signaling pathway to cyclin D(1) expression in airway smooth muscle cells. J. Biol. Chem. 274:1999;22065-22071.
70. Page S., Ammit A.J., Black J.L., Armour C.L. Human mast cell and airway smooth muscle cell interactions: implications for asthma. Am. J. Physiol. Lung Cell Mol. Physiol. 281:2001;L1313-L1323.
71. Page K., Li J., Hershenson M.B. p38 MAP kinase negatively regulates cyclin D1 expression in airway smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 280:2001;L955-L964.
72. Panettieri R.A. Jr, Lazaar A.L., Pure E., Albelda S.M. Activation of cAMP-dependent pathways in human airway smooth muscle cells inhibits TNF-alpha-induced ICAM-1 and VCAM-1 expression and T lymphocyte adhesion. J. Immunol. 154:1995;2358-2365.
73. Pang L., Knox A.J. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells. Br. J. Pharmacol. 121:1997;579-587.
74. Pang L., Knox A.J. Bradykinin stimulates IL-8 production in cultured human airway smooth muscle cells: role of cyclooxygenase products. J. Immunol. 161:1998;2509-2515.
75. Pang L., Nie M., Corbett L., Knox A.J. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors. J. Immunol. 170:2003;1043-1051.
76. Park C.S., Choi Y.S., Ki S.Y., Moon S.H., Jeong S.W., Uh S.T., Kim Y.H. Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways. Eur. Respir. J. 12:1998;872-878.
77. Parris J.R., Cobban H.J., Littlejohn A.F., MacEwan D.J., Nixon G.F. Tumour necrosis factor-alpha activates a calcium sensitization pathway in guinea-pig bronchial smooth muscle. J. Physiol. London. 518:(Pt. 2):1999;561-569.
78. Pyne S., Chapman J., Steele L., Pyne N.J. Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK) signal cascades in airway smooth muscle. Eur. J. Biochem. 237:1996;819-826.
79. Pype J.L., Dupont L.J., Menten P., Van Coillie E., Opdenakker G., Van Damme J., Fan C.K., Demedts M.G., Verleden G.M. Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and t- helper 2 cytokines [in process citation]. Am. J. Respir. Cell Mol. Biol. 21:1999;528-536.
80. Pype J.L., Xu H., Schuermans M., Dupont L.J., Wuyts W., Mak J.C., Barnes P.J., Demedts M.G., Verleden G.M. Mechanisms of interleukin 1beta-induced human airway smooth muscle hyporesponsiveness to histamine. Involvement of p38 MAPK NF-kappaB. Am. J. Respir. Crit Care Med. 163:2001;1010-1017.
81. Pyronnet S., Imataka H., Gingras A.C., Fukunaga R., Hunter T., Sonenberg N. Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E. EMBO J. 18:1999;270-279.
82. Ramakrishnan M., Musa N.L., Li J., Liu P.T., Pestell R.G., Hershenson M.B. Catalytic activation of extracellular signal-regulated kinases induces cyclin D1 expression in primary tracheal myocytes. Am. J. Respir. Cell Mol. Biol. 18:1998;736-740.
83. Reynolds A.M., Holmes M.D., Scicchitano R. Cytokines enhance airway smooth muscle contractility in response to acetylcholine and neurokinin A. Respirology. 5:2000;153-160.
84. Saunders M.A., Mitchell J.A., Seldon P.M., Yacoub M.H., Barnes P.J., Giembycz M.A., Belvisi M.G. Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone. Br. J. Pharmacol. 120:1997;545-546.
85. Schiemann W.P., Nathanson N.M. Involvement of protein kinase C during activation of the mitogen-activated protein kinase cascade by leukemia inhibitory factor. Evidence for participation of multiple signaling pathways. J. Biol. Chem. 269:1994;6376-6382.
86. Schiemann W.P., Graves L.M., Baumann H., Morella K.K., Gearing D.P., Nielsen M.D., Krebs E.G., Nathanson N.M. Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation. Proc. Natl. Acad. Sci. USA. 92:1995;5361-5365.
87. Shore S.A., Moore P.E. Effects of cytokines on contractile and dilator responses of airway smooth muscle. Clin. Exp. Pharmacol. Physiol. 29:2002;859-866.
88. Sohara N., Trojanowska M., Reuben A. Oncostatin M stimulates tissue inhibitor of metalloproteinase-1 via a MEK-sensitive mechanism in human myofibroblasts. J. Hepatol. 36:2002;191-199.
89. Stewart A.G., Tomlinson P.R., Wilson J. Airway wall remodeling in asthma: a novel target for the development of anti-asthma drugs. Trends Pharmacol. Sci. 14:1993;275-279.
90. Thoma B., Bird T.A., Friend D.J., Gearing D.P., Dower S.K. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J. Biol. Chem. 269:1994;6215-6222.
91. Van Wagoner N.J., Choi C., Repovic P., Benveniste E.N. Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38. J. Neurochem. 75:2000;563-575.
92. Wang X., Flynn A., Waskiewicz A.J., Webb B.L., Vries R.G., Baines I.A., Cooper J.A., Proud C.G. The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways. J. Biol. Chem. 273:1998;9373-9377.
93. Wang S.W., Pawlowski J., Wathen S.T., Kinney S.D., Lichenstein H.S., Manthey C.L. Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase. Inflamm. Res. 48:1999;533-538.
94. Waskiewicz A.J., Flynn A., Proud C.G., Cooper J.A. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16:1997;1909-1920.
95. Watson M.L., Grix S.P., Jordan N.J., Place G.A., Dodd S., Leithead J., Poll C.T., Yoshimura T., Westwick J. Interleukin 8 and monocyte chemoattractant protein 1 production by cultured human airway smooth muscle cells. Cytokine. 10:1998;346-352.
96. Wills-Karp M., Luyimbazi J., Xu X., Schofield B., Neben T.Y., Karp C.L., Donaldson D.D. Interleukin-13: central mediator of allergic asthma. Science. 282:1998;2258-2261.
97. Winzen R., Kracht M., Ritter B., Wilhelm A., Chen C.Y., Shyu A.B., Muller M., Gaestel M., Resch K., Holtmann H. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18:1999;4969-4980.
98. Yamboliev I.A., Hedges J.C., Mutnick J.L., Adam L.P., Gerthoffer W.T. Evidence for modulation of smooth muscle force by the p38 MAP kinase/HSP27 pathway. Am. J. Physiol. Heart Circ. Physiol. 278:2000;H1899-H1907.
99. Zhu W., Brauchle M.A., Di Padova F., Gram H., New L., Ono K., Downey J.S., Han J. Gene suppression by tristetraprolin and release by the p38 pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 281:2001;L499-L508.